TriSalus Life Sciences Taps James Young as CFO

Dow Jones
08 Jan
 

By Sabela Ojea

 

TriSalus Life Sciences said it promoted James Young to the finance chief position.

The oncology company said Young, who most recently served as treasurer, succeeds Sean Murphy.

Murphy will continue to serve the company as chief manufacturing, strategy and business development officer and as a board director.

The company also named Richard Marshak as its chief commercial officer and Jodi Devlin as the chief of clinical strategy and operations.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

January 08, 2025 08:24 ET (13:24 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10